Cardiovascular clinical trials in the era of a pandemic.

Siontis, George Cm; Sweda, Romy; Windecker, Stephan (2020). Cardiovascular clinical trials in the era of a pandemic. Journal of the American Heart Association, 9(20), e018288. American Heart Association 10.1161/JAHA.120.018288

[img]
Preview
Text
Cardiovascular clinical trials in the era of a pandemic.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (3MB) | Preview

COVID-19 has reached pandemic levels in March 2020 and impacted public health with unpredictable consequences.1, 2 The conduct of clinical research in areas unrelated to COVID-19 has been disrupted and will be further affected. Researchers, trial participants and study personnel have to overcome challenges to sustain proper and safe conduct of clinical trials (i.e. logistical challenges, lower enrollment than expected, difficulties in follow-up and outcome assessment/adjudication, incomplete data collection, research funding prolongation).

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Siontis, Georgios; Sweda, Romy and Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2047-9980

Publisher:

American Heart Association

Language:

English

Submitter:

Nadia Biscozzo

Date Deposited:

29 Nov 2020 15:16

Last Modified:

29 Nov 2020 19:50

Publisher DOI:

10.1161/JAHA.120.018288

PubMed ID:

32993467

Uncontrolled Keywords:

COVID‐19 cardiovascular disease cardiovascular research randomized controlled trial

BORIS DOI:

10.7892/boris.147490

URI:

https://boris.unibe.ch/id/eprint/147490

Actions (login required)

Edit item Edit item
Provide Feedback